Crossmark

Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors

Crossref DOI link: https://doi.org/10.1186/s12913-021-06827-0

Published Online: 2021-08-12

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bao, Yun

Gao, Bei

Meng, Min

Ge, Bin

Yang, Yan

Ding, Chunchun

Shi, Bingyin

Tian, Limin https://orcid.org/0000-0002-4769-4375
Funding

Funding for this research was provided by:

National Key R&D Program of China (2018YFC1311502)

Lanzhou Science and Technology Development Guiding Plan Project (2019-ZD-104)

National Natural Science Foundation of China (81760144)
License Information

Text and Data Mining valid from 2021-08-12

Version of Record valid from 2021-08-12
More Information

Article History

Received: 8 June 2020

Accepted: 27 July 2021

First Online: 12 August 2021

Declarations

:

: This study was based on a literature review and MCDA; This study did not require approval by an Institutional Research Ethics Board.

: Not applicable.

: Authors have no competing interests to declare.

Document is current

Any future updates will be listed below